INS and prediabetes syndrome: Given that the ELD and MID populations had neither prediabetes nor abnormal lipid profiles, it is not surprising that the HOMA-IR and QUICKI-IR (measures of IR based solely on fasting blood glucose and insulin) showed significant improvements in IR for those consuming MSPrebiotic® compared to placebo but LP-IR was not different.